Image: Michael A. Stramiello

Michael A. Stramiello

Associate, Litigation Department
Washington, D.C.
2050 M Street NW
Washington, D.C. 20036
United States

Fax: 1(202) 551-0458


Michael Stramiello, Ph.D., is an intellectual property litigation associate in Washington, DC. His practice focuses on the life sciences industry. He has handled patent disputes before the U.S. Patent & Trademark Office's Patent Trial & Appeal Board (PTAB), U.S. District Courts, the Federal Circuit, and the American Arbitration Association (AAA). His litigation experience includes:

  • developing strategies on validity and infringement;

  • leading work with expert and fact witnesses as they prepare to provide written and oral testimony;

  • taking and defending expert depositions;

  • drafting briefs and contentions; and

  • second-chairing oral arguments.

Dr. Stramiello also provides strategic counseling to biotechnology clients with respect to patent portfolio development, licensing and enforcement strategies, and inventorship issues. In addition, he has experience drafting and prosecuting biotechnology patent applications. Dr. Stramiello has handled matters involving various compositions (e.g., AAV, baculoviral, and lentiviral vectors, antibodies, antibody-drug conjugates, atypical antipsychotics, cannabinoids, CAR T cells, drug discovery platforms, hormones, microfluidics, nitrogen-scavenging drugs, NMDA receptor antagonists, norepinephrine-serotonin reuptake inhibitors, oligonucleotides, opioids, phosphodiesterase type-5 inhibitors, potassium channel antagonists, prodrugs, recombinant DNA, RNA-guided nucleases, selective serotonin reuptake inhibitors, thrombin inhibitors, vaccines, and virus-like particles), routes of administration (e.g., epicutaneous, injectable, oral, and sublingual), and methods (e.g., additive manufacturing, disease treatment, genome editing, protein purification, and transfection).

During law school, Dr. Stramiello trained in examination of biotechnology patent applications at the United States Patent & Trademark Office, externed at the U.S. District Court for the Northern District of Alabama, and worked as a commercialization analyst at the University of Alabama Office for Technology Transfer, where he analyzed invention disclosures, identified licensing opportunities, and assisted in contract negotiations. Before law school, he conducted graduate research on learning and memory disorders. His work involved pharmacological and electrophysiological characterizations of dopaminergic, GABAergic, glutamatergic, and serotonergic activity in the hippocampus.

Accolades and Recognitions

  • Certificate in Biologic Therapeutic Drug Development, University of Wisconsin-Madison Division of Pharmacy Professional Development, 2020

  • ABA Section of IP Law Recognition of Outstanding Leadership, 2018

  • Capital Pro Bono High Honor Roll, 2016

  • Bert W. Levit Essay Award for innovative research and writing in lawyers' professional liability, 2013

  • ABA-BNA Award for Excellence in the Study of IP Law, 2013

  • CALI Excellence for the Future Award for highest grades in Litigation Drafting, 2011

  • ARCS Award for accomplishment in biomedical research, 2009

  • UGA Dissertation Completion Award for academic performance, research achievement, and community service, 2009

  • Full-tuition academic scholarships for undergraduate, graduate, and legal education


  • University of Alabama School of Law, J.D.

  • University of Georgia, Ph.D.

  • University of Georgia, B.S. (cum laude)

Speaking Engagements


  • Landslide® Magazine Board: served as Deputy Editor-in-Chief (2020-present), Acquisitions/Intake Editor (2019-2020), Issue Editor (2015-2018), and Column Editor (2012-2014) 

  • PTAB Bar Association: Selected for Law Journal Editorial Board (2019-present); appointed as Vice Chair of the Program Committee (2019-present), as one of seven members of the Nominations Committee (2018 & 2019), and as Chair of the Young Lawyers & Agents Committee (2016-2017)

  • Law360: Selected for Life Sciences Editorial Advisory Board (2017)

Recent Representations

  • Daiichi Sankyo, in pursuing multiple PGRs against Seagen

  • Daiichi Sankyo, in declaratory judgment action against Seagen

  • Alkermes Pharma, in ANDA litigation

  • Global pharmaceutical company, in arbitration regarding biotechnology IP

  • BioMarin Pharmaceutical, in strategic counseling regarding biotechnology IP

  • Alkermes Pharma, in defending against an IPR filed by Amneal

  • Bluebird Bio, in strategic counseling regarding biotechnology IP

  • Adamas Pharmaceuticals, in ANDA litigation

  • Insys Therapeutics, in ANDA litigation

  • Sunovion Pharmaceuticals and Sumitomo Dainippon Pharma, in defending against an IPR filed by Par Pharmaceutical

  • Horizon Therapeutics, in an appeal to the Federal Circuit regarding an IPR final decision

  • BioMarin Pharmaceutical, in multiple appeals to the Federal Circuit regarding interference decisions

  • Acorda Therapeutics, in defending against multiple IPRs filed by Coalition For Affordable Drugs (ADROCA)

  • Helsinn Healthcare, in defending against multiple PGRs and IPRs filed by Dr. Reddy's Laboratories

  • Insys Pharma, in defending against multiple IPRs filed by Coalition For Affordable Drugs XI

  • AbbVie, in asserting multiple patents against Centocor

  • Eli Lilly & Company, in pursuing multiple IPRs against LA BioMed

  • Note: this is a partial list.

Practice Areas

Patent Office
Patent Litigation
Intellectual Property
Life Sciences and Healthcare




District of Columbia Bar
Virginia Bar
United States Patent & Trademark Office


University of Alabama School of Law, J.D. 2013
University of Georgia, Ph.D. 2010
University of Georgia, B.S. 2005